San Francisco, Calif./Antwerp, Belgium, October 11, 2017 – Byteflies, a Belgian-American wearable health start-up, launches the Byteflies Exploration Kit. The kit features a set of five programmable high-precision Sensor Dots that continuously and remotely monitor any vital sign. Data gathered through the wearable sensors then connect to Byteflies’ data processing platform.
With this solution, the company targets pharmaceutical companies, startups and research groups involved in clinical studies or the development of their own wearable health applications. The unprecedented level of detail offered by the Byteflies Exploration Kit forms the basis for a more powerful and personalized patient care.
Byteflies developed its Exploration Kit and flagship data platform based on insights gained through practical use cases and decades of experience in healthcare and technology applications. With a growing need for better patient follow-up, accelerated drug development and new insights into diseases, many organizations seek to explore the potential of health wearables. The current lack of tools and options was the catalyst for Byteflies to build its own Exploration Kit and data platform.
“Worldwide, around 46% of people suffer from a chronic condition. When it comes to monitoring their health, wearables have incredible potential. However, a wristband that counts steps and measures heart rate just won’t cut it when you’re developing solutions for Parkinson’s disease, pulmonary and cardiovascular conditions, hypertension, or epilepsy,” explains Hans Danneels, CEO and co-founder of Byteflies. “You need to be able to measure raw, accurate data – the kind of data collected in hospitals. That’s where our solution comes in.”
Easily programmable to specific use cases, the Byteflies sensors can measure different vital signs, ranging from blood flow (PPG) to electro-dermal activity (EDA), electrocardiogram (ECG), motion, respiration, and electromyogram (EMG). The technology is currently used by CWRU Cleveland, the University of Leuven (Belgium) and pharmaceutical company UCB for detection of epileptic seizures, blood pressure trends, balance, and fatigue.
With its Exploration Kit and accompanying data platform, the company breaks into the market for highly-specialized wearable health tools. “We seek to transform the entire healthcare system through our technology, leading to wearables with tangible medical relevance. Quality, a very high level of detail, and tech validation are our key concerns as we work closely with our clients,” says Hans Danneels.